Artificial intelligence is no longer a niche bet on the edge of the tech sector, it is the organizing principle for a market ...
The company will use the funds to accelerate commercialization of its brain-signal AI technology and expand its cognitive health applications.
Blood-based Biomarker for Alzheimer’s Disease Market to reach US$ 554.2 Mn by 2035 at 14.3% CAGR, driven by demand for ...
Now, the CEO has escalated the issue from the Aave governance forum to Snapshot, allowing individual token holders to also ...
PALM BEACH, Florida, Dec 25 (Reuters) – The White House will unveil new details on President Donald Trump’s planned East Wing ballroom during a hearing early next month, according… Read More ...